About SkinAI™
The pandemic has placed an incredible burden on the healthcare system, and, unfortunately, skin cancer screenings have plummeted resulting in an alarming trend where initial late-stage skin cancer diagnoses are increasing at a rapid pace.
SkinAI™ technology was created so that people who fear the threat of skin disease or skin cancer could get a preliminary analysis as to the urgency of their lesions, without the need to wait months for an appointment or risk close contact with someone with Covid19.
Since the technology is geographically agnostic, we are also able to deploy it to under-serviced regions and provide people with unparalleled access to healthcare.
